טוען...
Who should get long-term anticoagulant therapy for venous thromboembolism and with what?
After an initial 3 to 6 months of anticoagulation for venous thromboembolism (VTE), clinicians and patients face an important question: “Do we stop anticoagulants or continue them indefinitely?” The decision is easy in some scenarios (eg, stop in VTE provoked by major surgery). In most scenarios, wh...
שמור ב:
| הוצא לאור ב: | Blood Adv |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Hematology
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6234370/ https://ncbi.nlm.nih.gov/pubmed/30425073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018020230 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|